Luangtongkum Taradon, Jeon Byeonghwa, Han Jing, Plummer Paul, Logue Catherine M, Zhang Qijing
Department of Veterinary Microbiology & Preventive Medicine, 1116 Veterinary Medicine Complex, Iowa State University, Ames, IA 500111, USA.
Future Microbiol. 2009 Mar;4(2):189-200. doi: 10.2217/17460913.4.2.189.
Campylobacter is a leading foodborne bacterial pathogen, which causes gastroenteritis in humans. This pathogenic organism is increasingly resistant to antibiotics, especially fluoroquinolones and macrolides, which are the most frequently used antimicrobials for the treatment of campylobacteriosis when clinical therapy is warranted. As a zoonotic pathogen, Campylobacter has a broad animal reservoir and infects humans via contaminated food, water or milk. Antibiotic usage in both animal agriculture and human medicine, can influence the development of antibiotic-resistant Campylobacter. This review will describe the trend in fluoroquinolone and macrolide resistance in Campylobacter, summarize the mechanisms underlying the resistance to various antibiotics and discuss the unique features associated with the emergence, transmission and persistence of antibiotic-resistant Campylobacter. Special attention will be given to recent findings and emphasis will be placed on Campylobacter resistance to fluoroquinolones and macrolides. A future perspective on antibiotic resistance and potential approaches for the control of antibiotic-resistant Campylobacter, will also be discussed.
弯曲杆菌是一种主要的食源性细菌病原体,可导致人类患肠胃炎。这种致病生物对抗生素的耐药性日益增强,尤其是对氟喹诺酮类和大环内酯类抗生素,当需要进行临床治疗时,这两类抗生素是治疗弯曲杆菌病最常用的抗菌药物。作为一种人畜共患病原体,弯曲杆菌有广泛的动物宿主,并通过受污染的食物、水或牛奶感染人类。动物养殖业和人类医学中的抗生素使用,都会影响耐抗生素弯曲杆菌的产生。本综述将描述弯曲杆菌对氟喹诺酮类和大环内酯类抗生素的耐药趋势,总结对各种抗生素耐药的潜在机制,并讨论与耐抗生素弯曲杆菌的出现、传播和持续存在相关的独特特征。将特别关注近期的研究发现,并重点讨论弯曲杆菌对氟喹诺酮类和大环内酯类抗生素的耐药性。还将讨论抗生素耐药性的未来前景以及控制耐抗生素弯曲杆菌的潜在方法。